'Neuroendocrine tumors' diaporamas de présentation

The Pathologic classification of Neuroendocrine Tumors

The Pathologic classification of Neuroendocrine Tumors. A.Sadeghipour M.D. Associate Professor of Pathology and Lab. Medicine Iran University of Medical sciences. Why Neuroendocrine Tumors?. 50% OF THE NEUROENDOCRINE TUMORS ARE DIAGNOSED WHEN IN ADVANCED STAGES.

740 views • 72 slides

MASOUD MOSLEHI NUCLEAR PHYSICIAN

MASOUD MOSLEHI NUCLEAR PHYSICIAN. Nuclear Medicine in Neuroendocrine Tumors. Somatostatin Receptor Scintigraphy. Somatostatin receptors common sites. Nervous system Endocrine glands Immune system GI tract. SSR: Normal sites. Brain Kidney GI

748 views • 70 slides

The tumors originate from a group of cells widely dispersed in different organs.

An Overview of Neuroendocrine T umors Ali A Ghazi M.D. Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences. Tehran, Iran.

887 views • 58 slides

CHAPTER 15

CHAPTER 15. THE LUNG. LUNG. NORMAL PATHOLOGY. Congenital Atalectasis Acute Injury Obstructive vs. Restrictive Obstructive Restrictive. Vascular Infections Transplant Tumors Pleura. PATHOLOGY. Congenital Anomalies. Atalectasis (Collapse). Acute Lung Injury.

942 views • 54 slides

Diagnosis and treatment of neuroendocrine tumors

Diagnosis and treatment of neuroendocrine tumors. Dan Granberg. Carcinoids Bronchial Thymic Gastric Duodenal Small bowel Appendiceal Large bowel Rectal. Endocrine pancreatic tumors Gastrinomas Insulinomas Glucagonomas VIPomas Somatostatinomas Non-functioning Mixed.

1.97k views • 47 slides

Diagnosis and treatment of neuroendocrine tumors

Diagnosis and treatment of neuroendocrine tumors. Dan Granberg. Carcinoids Bronchial Thymic Gastric Duodenal Small bowel Appendiceal Large bowel Rectal. Endocrine pancreatic tumors Gastrinomas Insulinomas Glucagonomas VIPomas Somatostatinomas Non-functioning Mixed.

491 views • 47 slides

Basic ICD-10-CM Coding 2013 Edition

444 views • 44 slides

The Pathology of Neuroendocrine Tumors: Diagnosis, Grading and Staging

The Pathology of Neuroendocrine Tumors: Diagnosis, Grading and Staging. Wendy L. Frankel, MD Vice Chair and Director of AP The Ohio State University Columbus, OH. Overview GI and Pan NET. Diagnosis Typical H&E, immunohistochemical stains Variants and mixed tumors Differential diagnosis

2.1k views • 33 slides

DIFFUSE HORMONAL SYSTEMS AND ENDOCRINE TUMOR SYNDROMES

DIFFUSE HORMONAL SYSTEMS AND ENDOCRINE TUMOR SYNDROMES. Hasan AYDIN, MD ; Yeditepe University Medic al Faculty; Department of Endocrinology and Metabolism. THE ORIGIN OF NEUROENDOCRINE TUMORS. NET originates from APUD ( Amine Precursor Uptake and Decarboxylation ) cells.

597 views • 33 slides

Clinical Trials

Clinical Trials. The Way We Make Progress Against Disease. What Are Clinical Trials?. Research studies involving people Try to answer scientific questions and find better ways to prevent, diagnose, or treat disease. Why Is Participation in Clinical Trials Important?.

814 views • 31 slides

Neuroendocrinal Tumors : A Case of Mistaken Identity.

295 views • 29 slides

PANCREATIC NEUROENDOCRINE TUMORS

630 views • 25 slides

Review on Rectal Carcinoid

292 views • 24 slides

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

1.21k views • 21 slides

Neuroendocrine Tumors Market

Neuroendocrine tumors are a complex group of tumors that develop predominantly in the digestive or respiratory tracts, but can occur in many areas of the body.

117 views • 11 slides

Diarrhea

Diarrhea. Chronic. Sub-Acute. Acute. < 14 days. > 14 days and <4 weeks. > 4 weeks. >3 times in 24h or >1 L in 24h. >3 times in 24h. Unusually soft or liquid. A quick word about acute diarrhea.

173 views • 11 slides

Neuroendocrine Tumors Market

Neuroendocrine tumors (NETs) consists of complex group of tumors that arise from cells called neuroendocrine cells.

109 views • 10 slides

Neuroendocrine Tumors Therapeutics Industry Report H1 2017

Global latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

69 views • 4 slides

Neuroendocrine Tumor Treatment Market Witness Considerable Growth To 2025

The global neuroendocrine tumor treatment market was valued at US$ 1,197.3 million in 2015 and is expected to witness a CAGR of 10.5% By 2025

32 views • 3 slides

Melissa Mathison Loses Battle with Neuroendocrine Cancer

(1888 PressRelease) Melissa Mathison, screenwriter best known for "E.T. the Extra-Terrestrial," dies of neuroendocrine cancer at 65.

73 views • 1 slides